159 results on '"PORTARENA, ILARIA"'
Search Results
2. Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer
3. Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency
4. MR imaging-guided vacuum assisted breast biopsy: Radiological-pathological correlation and underestimation rate in pre-surgical assessment
5. Socioeconomic Impact of OncotypeDX on Breast Cancer Treatment: Preliminary Results.
6. The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies
7. Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab
8. Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
9. Radiological and Pathological Predictors of Post-Operative Upstaging of Breast Ductal Carcinoma in Situ (Dcis) to Invasive Ductal Carcinoma and Lymph-Nodes Metastasis; a Potential Algorithm for Node Surgical De-Escalation
10. Current challenges in HER2-positive breast cancer
11. FEASIBILITY AND SAFETY OF AWAKE ONCOPLASTIC SURGERY FOR BREAST CANCER
12. Awake Breast Conservative Surgery: A Strategy to Shorten Surgical Waiting Lists During and Post COVID-19 Emergency
13. Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt
14. Novel High-Sensitive D-Dimer Determination Predicts Chemotherapy-Associated Venous Thromboembolism in Intermediate Risk Lung Cancer Patients
15. The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature
16. Impact of COVID-19 Pandemic on Surgical Breast Cancer Patients Undergoing Neoadjuvant Therapy: A Multicentric Study
17. Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer
18. Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients—a pilot study
19. Advanced Stages and Increased Need for Adjuvant Treatments in Breast Cancer Patients: The Effect of the One-year COVID-19 Pandemic
20. Factors influencing diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic and biliary tumors
21. CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives
22. Lymphocytes, Interleukin 6 and D-dimer Cannot Predict Clinical Outcome in Coronavirus Cancer Patients: LyNC1.20 Study
23. Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes
24. Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components
25. Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency
26. Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery
27. The Effect of Coronavirus (COVID-19) on Breast Cancer Teamwork: A Multicentric Survey
28. Evaluation of Concordance Between Histopathological, Radiological and Biomolecular Variables in Breast Cancer Neoadjuvant Treatment
29. Serum sE-Selectin Levels and Carcinoembryonic Antigen mRNA-Expressing Cells in Peripheral Blood as Prognostic Factors in Colorectal Cancer Patients
30. Valproic Acid Increases the Stimulatory Effect of Estrogens on Proliferation of Human Endometrial Adenocarcinoma Cells
31. CRH Inhibits Cell Growth of Human Endometrial Adenocarcinoma Cells via CRH-Receptor 1-Mediated Activation of cAMP-PKA Pathway
32. Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience
33. Evaluation of the Usefulness of FDG-PET/CT for Nodal Staging of Breast Cancer
34. Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors
35. Prognostic Significance of Neutrophil–to–lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer
36. BMI and health-related quality of life (HR-QoL) in patients with metastatic colorectal cancer (mCRC).
37. New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes
38. Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression
39. Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass
40. P-0110 The Influence of Prognostic Factors on Survival in Patients with Advanced Pancreatic Cancer Evaluated in not Referred Centre
41. Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients
42. An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients
43. W1154 EUS Accuracy in Restaging Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Preliminary Report
44. Prognostic Value of Carcinoembryonic Antigen and Vascular Endothelial Growth Factor Tumor Tissue Content in Colorectal Cancer
45. N3-Methyladenine Induces Early Poly(ADP-Ribosylation), Reduction of Nuclear Factor-κB DNA Binding Ability, and Nuclear Up-Regulation of Telomerase Activity
46. Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined with Poly (ADP-Ribose) Polymerase Inhibitor
47. Poly(ADP‐ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells
48. Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site
49. Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells.
50. N3-Methyladenine Induces Early Poly(ADP-Ribosylation), Reduction of Nuclear Factor-κB DNA Binding Ability, and Nuclear Up-Regulation of Telomerase Activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.